Posted on 11/5/20
Sage Therapeutics Announces Third Quarter 2020 Financial Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Today, Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with . . .
Posted on 11/5/20
Concert Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Company Update
LEXINGTON, Mass.--(BUSINESS WIRE)--Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the third quarter of 2020.“Our focus this year has been to advance our proprietary . . .
Posted on 11/5/20
Karuna Therapeutics Reports Third Quarter 2020 Financial Results and Provides General Business Update
BOSTON--(BUSINESS WIRE)--Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with . . .
Posted on 11/5/20
Modalis Therapeutics Reports Third Quarter 2020 Financial Results and Operational Highlights
TOKYO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Modalis Therapeutics Corporation (TOKYO: 4883), a leading company developing innovative products for the treatment of rare genetic diseases utilizing its proprietary CRISPR-GNDM epigenetic . . .
Posted on 11/5/20
National Vision Holdings Reports Third Quarter 2020 Financial Results
DULUTH, Ga.--(BUSINESS WIRE)--National Vision Holdings, Inc. (NASDAQ: EYE) today reported its financial results for the third quarter ended September 26, 2020.“The National Vision team delivered an . . .
Posted on 11/5/20
Rexahn Pharmaceuticals Announces Expected Effectiveness of Reverse Stock Split
ROCKVILLE, Md., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NASDAQ:REXN) announced today that the merger transaction between Rexahn and Ocuphire Pharma, Inc. is expected . . .
Posted on 11/5/20
COVID-19 Relief Programs Available For Maryland Restaurants, Artists, And Entertainment Venues
As part of Governor Hogan’s latest $250 million relief package for those impacted by the COVID-19 pandemic, new financial assistance is now available to restaurants, independent . . .
Posted on 11/5/20
Esteemed Panel of National Experts to Lead Peer-to-Peer Healthcare Technology Security Symposium
Private event for healthcare cybersecurity executives comes amidst new cybercriminal threats to care providers CyberRisk Alliance (CRA), a business intelligence company serving the cybersecurity and information . . .
Posted on 11/5/20
Kobiton Acquires Mobile Labs
ATLANTA, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Mobile Experience Platform leader Kobiton announces the acquisition of best-in-class on-premises mobile testing platform, Mobile Labs Inc. The combined . . .
Posted on 11/5/20
Bellerophon Provides Clinical Program Update and Reports Third Quarter 2020 Financial Results
WARREN, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary and infectious diseases, . . .
Posted on 11/5/20
Radius Health Third Quarter 2020 Operating Results
WALTHAM, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), today reported its financial and operating results for the third quarter ended September . . .
Posted on 11/5/20
Prestige Consumer Healthcare Reports Fiscal 2021 Second Quarter Results
TARRYTOWN, N.Y., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its second quarter and first six months ended . . .
Posted on 11/5/20
Replimune Reports Fiscal Second Quarter Financial Results and Provides Corporate Update
WOBURN, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic™ platform, today . . .
Posted on 11/5/20
Agios Reports Business Highlights and Third Quarter 2020 Financial Results
CAMBRIDGE, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism to treat cancer and rare . . .
Posted on 11/5/20
22nd Century Group Reports Financial Results and Business Highlights for the Third Quarter 2020
WILLIAMSVILLE, N.Y., Nov. 05, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm . . .
Posted on 11/5/20
Imara Reports Third Quarter 2020 Financial Results and Business Highlights
BOSTON, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering . . .
Posted on 11/5/20
Athenex Reports Third Quarter Ended September 30, 2020 Financial Results and Provides Corporate Update
BUFFALO, N.Y., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies . . .
Posted on 11/5/20
BioCryst Reports Third Quarter 2020 Financial Results
RESEARCH TRIANGLE PARK, N.C., Nov. 05, 2020 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced financial results for the third quarter ended September 30, 2020, . . .
Posted on 11/5/20
EyePoint Pharmaceuticals Reports Third Quarter 2020 Financial Results and Highlights Recent Corporate Developments
WATERTOWN, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced . . .
Posted on 11/5/20
X4 Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
BOSTON, Nov. 05, 2020 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting diseases resulting from . . .
Posted on 11/5/20
Axsome Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
NEW YORK, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system . . .
Posted on 11/5/20
Intellia Therapeutics Announces Third Quarter 2020 Financial Results
CAMBRIDGE, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both . . .
Posted on 11/5/20
Albireo Reports Q3 2020 Financial Results and Provides Business Update
BOSTON, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare liver disease company developing novel bile acid modulators, today provided a . . .
Posted on 11/5/20
Dyne Therapeutics Reports Third Quarter 2020 Financial Results
WALTHAM, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing innovative life-transforming therapeutics for people living . . .
Posted on 11/5/20
Vericel Reports Record Third Quarter Revenues and Net Income
CAMBRIDGE, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today . . .

